Premium
Growth factors during HCV therapy may be “cost‐effective”, but are they “effective”?
Author(s) -
Muir Andrew J.,
McHutchison John G.
Publication year - 2006
Publication title -
hepatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.488
H-Index - 361
eISSN - 1527-3350
pISSN - 0270-9139
DOI - 10.1002/hep.21426
Subject(s) - ribavirin , medicine , hepatitis c virus , anemia , erythropoietin , hepatitis c , hepatology , clinical trial , intensive care medicine , granulocyte colony stimulating factor , epoetin alfa , immunology , virus , chemotherapy